Radico Khaitan's quarterly results were below expectations, with sales, EBITDA, and PAT missing targets. Volume declined 3.5% due to a strategy to de-focus on regular brands amidst raw material inflation. Premium brands grew 12.3% but only contribute 20.8% of volume. Margins contracted as expenses increased and the company did not receive any price hikes. The analyst revised estimates down 20-25% and maintained a Buy rating but with a reduced target price, citing near-term challenges but intact long-term prospects. Spike in input costs remains a key risk.
Radico Khaitan's quarterly results were below expectations, with sales, EBITDA, and PAT missing targets. Volume declined 3.5% due to a strategy to de-focus on regular brands amidst raw material inflation. Premium brands grew 12.3% but only contribute 20.8% of volume. Margins contracted as expenses increased and the company did not receive any price hikes. The analyst revised estimates down 20-25% and maintained a Buy rating but with a reduced target price, citing near-term challenges but intact long-term prospects. Spike in input costs remains a key risk.
Radico Khaitan's quarterly results were below expectations, with sales, EBITDA, and PAT missing targets. Volume declined 3.5% due to a strategy to de-focus on regular brands amidst raw material inflation. Premium brands grew 12.3% but only contribute 20.8% of volume. Margins contracted as expenses increased and the company did not receive any price hikes. The analyst revised estimates down 20-25% and maintained a Buy rating but with a reduced target price, citing near-term challenges but intact long-term prospects. Spike in input costs remains a key risk.
Radico Khaitan's quarterly results were below expectations, with sales, EBITDA, and PAT missing targets. Volume declined 3.5% due to a strategy to de-focus on regular brands amidst raw material inflation. Premium brands grew 12.3% but only contribute 20.8% of volume. Margins contracted as expenses increased and the company did not receive any price hikes. The analyst revised estimates down 20-25% and maintained a Buy rating but with a reduced target price, citing near-term challenges but intact long-term prospects. Spike in input costs remains a key risk.
0.9 1.1 1.3 Results well below expectations: Radico Khaitans 1QFY15 performance was weak with volume, sales, EBITDA and PAT coming well below expectations. Lack of price increases from state governments, RM inflation coupled with strategy to defocus on regular portfolio marred the quarterly results. Sales grew muted 3.5% to INR3.7b (est. INR4.1b). Gross margins contracted 90bp YoY to 52.2% led by RM inflation. (ENA prices up 8.5% YoY, as per management). Increase in ad spends (up 80bp YoY to 20%), staff (up 100bp YoY to 6.5%) and other expenses (up 80bp YoY to 12.1%) further dragged EBITDA margin (down 350bp YoY) to 13.6% (est. 17.2%). Thus EBITDA posted decline of 17.9% YoY to INR501m (est. INR707m). Higher interest (up 10% YoY), depreciation expense (up 11% YoY) and other income (up 10% YoY) led to PBT decline of 33.3% to INR264m (est. INR462m). Adj. PAT was impacted by higher tax rates (up 760bp YoY) and posted 39.9% YoY decline to INR 184m (est. INR 337 m). Reported PAT declined 26.5 % due to exceptional item pertaining to forex loss. Volumes declined 3.5% YoY to 5.35m cases. Premium brands grew 12.3% YoY to 1.1m cases and contributed 20.8% of portfolio volumes (up 290bps YoY). Radico will hold back on Regular portfolio till it gets price hike. Therefore, we have lowered our FY15 volume growth estimates to 2%. Net debt stood at INR 8.75b, as per management. We have revised our estimates downwards by 20-25% to adjust for 1Q miss and sharp downward revision in FY15 guidance. We now build in 2% volume growth for FY15 vs. earlier 7% growth assumption. Cut earnings 20-25%: Notwithstanding the attractive long term industry dynamics, a challenging FY15 awaits Radico as it maneuvers portfolio mix shift amidst challenging operating environment. While our belief in the Radico story remains intact, we do see near term weakness in the stock. It trades at 16.2x FY15 and 13.5x FY16 estimates. Maintain Buy with a revised TP of INR 115. Spike in ENA price is a key downside risk.
Investors are advised to refer through disclosures made at the end of the Research Report.
13 August 2013 2
Radico Khaitan Net sales growth muted at 3.6% Net sales grew by 3.6% to INR 3.6b while net sales including other operating income posted 3.5% YoY growth to INR 3.7b (est INR 4.1b).Company posted 3.5% volume decline to 5.35m cases. Premium brands grew 12.3% YoY to 1.1m cases and contributed 20.8% of portfolio volumes (16.1% in 1QFY14, 17.3% in 4QFY14). Regular brands posted 6.9 % decline in volumes to 4.3m cases. Lack of price increases from state governments is leading Radico to adopt a strategy of defocusing on Regular brands in an inflationary RM regime.
Volume decline led by defocus on Regular portfolio
Source: Company, MOSL premium brands now constitute 20.8% of portfolio
Source: Company, MOSL
1Q15 volumes down 3.5%, premium brands volumes up 12.3% (in lakh cases) Brands 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 3QFY13 4QFY13 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 Magic Moments Vodka 6.2 5.2 5.8 5.1 7.3 6.0 6.8 NA NA NA NA NA NA Morpheus Brandy 0.7 0.9 1.1 0.9 1.1 1.2 1.5 NA NA NA NA NA NA Premium Brands 6.9 6.1 6.9 6.0 8.4 7.3 8.2 7.0 9.9 8.9 10.2 8.2 11.1 Other Main Line Brands 27.7 24.5 25.7 24.5 29.9 26.2 27.4 26.6 31.5 27.4 42.7 38.9 42.4 Total main line brands 34.6 30.6 32.6 30.5 38.3 33.4 35.6 33.5 41.4 36.2 52.9 47.1 53.6 Other brands 13.0 11.1 12.6 11.9 13.3 11.5 12.6 12.0 14.1 11.9 0.0 0.0 0.0 Total 47.6 41.7 45.2 42.5 51.5 44.9 48.2 45.5 55.5 48.1 52.9 47.1 53.6 Source: Company, MOSL
ENA prices increased 8.5% YoY (as per management) and the company has not got any price hike since 1QFY14. Radico is engaging with several state governments and management expects price hike to materialize in 2H.
Revenues grew 3.5% in 1Q
Source: Company, MOSL ENA prices up 8.5% YoY
Source: Company, MOSL 12.3 9.7 10.5 6.8 8.2 7.8 6.5 7.2 7.6 7.2 9.9 3.5 (3.5) 1 Q F Y 1 2 2 Q F Y 1 2 3 Q F Y 1 2 4 Q F Y 1 2 1 Q F Y 1 3 2 Q F Y 1 3 3 Q F Y 1 3 4 Q F Y 1 3 1 Q F Y 1 4 2 Q F Y 1 4 3 Q F Y 1 4 4 Q F Y 1 4 1 Q F Y 1 5 Volume Growth (%) 7.9 10.3 13.2 14.6 16.2 16.1 17.1 19.3 17.3 18.3 20.8 F Y 0 9 F Y 1 0 F Y 1 1 F Y 1 2 F Y 1 3 Q 1 F Y 1 4 Q 2 F Y 1 4 Q 3 F Y 1 4 Q 4 F Y 1 4 F Y 1 4 1 Q F Y 1 5 Premium brand volume as % of total volumes 3 , 0 3 8 2 , 9 7 0 3 , 2 6 0 3 , 3 1 5 3 , 5 7 3 3 , 5 2 1 3 , 9 0 9 3 , 5 1 4 3 , 6 9 9 2.1 13.9 8.1 16.8 17.6 18.5 19.9 6.0 3.5 1 Q F Y 1 3 2 Q F Y 1 3 3 Q F Y 1 3 4 Q F Y 1 3 1 Q F Y 1 4 2 Q F Y 1 4 3 Q F Y 1 4 4 Q F Y 1 4 1 Q F Y 1 5 Net Sales (INR m) Sales Growth (%) 36.9 40.3 41.6 39.2 36.9 41.3 43.7 43.1 41.7 43.7 45.4 44.5 45.2 1 Q F Y 1 2 2 Q F Y 1 2 3 Q F Y 1 2 4 Q F Y 1 2 1 Q F Y 1 3 2 Q F Y 1 3 3 Q F Y 1 3 4 Q F Y 1 3 1 Q F Y 1 4 2 Q F Y 1 4 3 Q F Y 1 4 4 Q F Y 1 4 1 Q F Y 1 5 ENA Price (INR/BL)
13 August 2013 3
Radico Khaitan EBITDA margins contracted 350bp YoY Gross margins contracted 90bp YoY to 52.2% led by raw material inflation. (ENA prices up 8.5% YoY, as per management). Increase in ad spends (up 80bp YoY to 20%), staff (up 100bp YoY to 6.5%) and other expenses (up 80bp YoY to 12.1%) further dragged EBITDA margin (down 350bp YoY) to 13.6% (est. 17.2%). Thus EBITDA posted decline of 17.9% YoY to INR501m (est. INR707m). Higher interest (up 10% YoY), depreciation expense (up 11% YoY) and other income (up 10% YoY) led to PBT decline of 33.3% to INR264m (est. INR462m). Adj. PAT was impacted by higher tax rates (up 760bp YoY) and posted in 39.9% YoY decline to INR 184m (est. INR 337 m). Reported PAT declined 26.5 % due to exceptional item pertaining to forex loss.
Gross margins contracted 90bp YoY
Source: Company, MOSL while EBITDA margins contracted 350bp
Source: Company, MOSL
Valuation and view We have revised our estimates downwards by 20-25% to adjust for 1Q miss and guidance for gradual volume recovery. Notwithstanding the attractive long term industry dynamics, a challenging FY15 awaits Radico as it maneuvers portfolio mix shift amidst challenging operating environment. While our belief in the Radico story remains intact, we do see near term weakness in the stock. It trades at 16.2x FY15 and 13.5x FY16 estimates. Maintain BUY with a revised TP of INR 115. Spike in ENA prices and excise duty increase are key risks.
50.1 51.6 48.7 59.0 58.1 54.7 50.3 51.5 53.1 52.7 53.1 61.4 52.2 1 Q F Y 1 2 2 Q F Y 1 2 3 Q F Y 1 2 4 Q F Y 1 2 1 Q F Y 1 3 2 Q F Y 1 3 3 Q F Y 1 3 4 Q F Y 1 3 1 Q F Y 1 4 2 Q F Y 1 4 3 Q F Y 1 4 4 Q F Y 1 4 1 Q F Y 1 5 Gross margin (%) 14.4 17.0 14.8 14.0 17.3 16.5 15.3 12.2 17.1 16.0 14.1 11.4 13.6 1 Q F Y 1 2 2 Q F Y 1 2 3 Q F Y 1 2 4 Q F Y 1 2 1 Q F Y 1 3 2 Q F Y 1 3 3 Q F Y 1 3 4 Q F Y 1 3 1 Q F Y 1 4 2 Q F Y 1 4 3 Q F Y 1 4 4 Q F Y 1 4 1 Q F Y 1 5 EBITDA margin (%)
13 August 2013 4
Radico Khaitan
Company name: an investment profile Company description Radico Khaitan (RDCK) is India's oldest alcoholic beverage company. It entered the IMFL segment in 1999, with the launch of its flagship brand, 8PM. RDCK has three distilleries in Rampur, UP and holds 36% interest in a JV in Aurangabad, Maharashtra. It owns six bottling units and maintains 27 contract bottling units. It holds 8% market share in the IMFL industry and ~24% market share in the CSD segment. The company offers all types of liquor, except for beer and wine, in regular and premium categories. Key investment arguments Radico is a pure India play on the huge growth opportunity in the IMFL space. Rising sales of Magic Moments Vodka and new launches (After Dark Whisky, Morpheus brandy) in the premium segment will reduce dependence on mass segment and improve profitability. A large spirits capacity, a pan India distribution (second only to United Spirits) and increasing focus on premium segment gives Radico an edge over other emerging IMFL players. Key investment risks Increasing competition can reduce the success rate for new launches in premium segment as many mid- sized players are eyeing this segment. Firm molasses prices and higher glass bottle costs could restrict margin expansion going ahead. Govt regulations regarding distribution, pricing and taxes on IMFL and inputs (Molasses and Grain) are a threat to industry profitability and cash flows. Valuation and view Our core Buy thesis on Radico Khaitan is playing out as premium brands continue to outperform the other mainline brands in the portfolio. Our conviction on the longer term growth story, driven by underlying premiumization, remains intact. The stock trades at 16.2x FY15E and 13.5x FY16E EPS. We reiterate Buy, with TP INR115. Sector view Long term potential remains favorable given demographics, high entry barriers and consolidation of the industry. Companies with wide product portfolio, premium brands and presence across segments will lead the growth rates and margin expansions. Comparative valuations Radico UNSP P/E (x) FY15E 16.2 61.7 FY16E 13.5 37.9 P/BV (x) FY15E 1.4 3.9 FY16E 1.3 3.6 EV/Sales (x) FY15E 1.3 3.4 FY16E 1.2 3.0 EV/EBITDA (x) FY15E 9.9 31.2 FY16E 8.8 24.2
Disclosures This research report has been prepared by MOSt to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies). This report is for personal information of the select recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur.
MOSt and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We and our affiliates have investment banking and other business relationships with a significant percentage of the companies covered by our Research Department Our research professionals provide important input into our investment banking and other business selection processes. Investors should assume that MOSt and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that the research professionals who were involved in preparing this material may participate in the solicitation of such business. The research professionals responsible for the preparation of this document may interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting market information. Our research professionals are paid in part based on the profitability of MOSt which include earnings from investment banking and other business. MOSt generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, MOSt generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest . MOSt and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent MOSts interpretation of the data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not intended to be a complete statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations.
Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents.
MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report.
Disclosure of Interest Statement RADICO KHAITAN Analyst ownership of the stock No
Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues.
Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions.
For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons.
For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons.
This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account.
For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Anosh Koppikar Kadambari Balachandran Email:anosh.Koppikar@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com Contact(+65)68189232 Contact: (+65) 68189233 / 65249115 Office Address:21 (Suite 31),16 Collyer Quay,Singapore 04931